Loading clinical trials...
Loading clinical trials...
Ziconotide is a strong analgesic marketed since 2005 in Europe and reserved for the intrathecal route. Its efficacy has been proven in particular by 3 randomized clinical studies. It is particularly ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Institut Cancerologie de l'Ouest
Collaborators
NCT06779578 · Trigeminal Neuralgia, Refractory Pain
NCT05165901 · Neuropathic Pain, Pain, and more
NCT07545928 · Palliative Care, Refractory Pain, and more
NCT04479787 · Chronic Low-Back Pain, Refractory Pain, and more
NCT02198404 · Refractory Pains, End of Life Patients
Institut de Cancerologie de L'Ouest
Angers
Centre Hospitalier Departemental La Roche Sur Yon
La Roche-sur-Yon
Centre Leon Berard
Lyon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions